Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study

C. Crimi (Catania (CT), Italy), G. Cacopardo (Catania (CT), Italy), S. Nolasco (Catania (CT), Italy), R. Campisi (Catania (CT), Italy), L. Spicuzza (Catania (CT), Italy), N. Crimi (Catania (CT), Italy)

Source: Virtual Congress 2020 – Air pollution and comorbidities
Session: Air pollution and comorbidities
Session type: E-poster session
Number: 134
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Crimi (Catania (CT), Italy), G. Cacopardo (Catania (CT), Italy), S. Nolasco (Catania (CT), Italy), R. Campisi (Catania (CT), Italy), L. Spicuzza (Catania (CT), Italy), N. Crimi (Catania (CT), Italy). Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study. 134

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
HRCT features in patients with severe asthma and non-cystic fibrosis bronchiectasis.
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Role of non-cystic fibrosis bronchiectasis in hospitalized patients with acute exacerbation of COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017

Assessing response to treatment of exacerbations of bronchiectasis in adults
Source: Eur Respir J 2009; 33: 312-318
Year: 2009



Patients hospitalised with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016

Clinical and functional profile of patients with non-cystic fibrosis bronchiectasis according to the presence of chronic bronchial infection
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


Factors associated with recurrence of severe exacerbations in Non-cystic fibrosis bronchiectasis in developping countries.
Source: International Congress 2019 – Clinical problems
Year: 2019

The experience of patients with cystic fibrosis during pulmonary exacerbations: a mixed-method study
Source: International Congress 2017 – Nursing practice across respiratory care pathways
Year: 2017

Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010


Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
Source: Virtual Congress 2020 – Monoclonal antibodies in asthma
Year: 2020


Diagnosis and management of non-cystic fibrosis bronchiectasis in children
Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment
Year: 2018


Non-cystic fibrosis bronchiectasis in children
Source: Annual Congress 2005 - MP11 - Non-cystic fibrosis bronchiectasis in children
Year: 2005

Non-cystic fibrosis bronchiectasis in children
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021


The prevalence of non-cystic fibrosis bronchiectasis in a pediatric respiratory unit
Source: International Congress 2018 – Orphan diseases in children
Year: 2018


Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Predictive factors for severe pulmonary exacerbations in patients with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 715s
Year: 2006

Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

Differences in clinical features and biomarkers of subsequent acute cystic fibrosis pulmonary exacerbations - Analysing exacerbations as separate entities
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Pulmonary arterial enlargement is a predictor of higher risk of exacerbations in non-cystic fibrosis bronchiectasis patients
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021


Occurrence and impact of bronchiectasis in patients with COPD
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017


Changing characteristics of childhood non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011